Skip to content
Screener

Stryker SYK MedSurg and Neurotechnology: — Segment operating income

Other segment segments

Orthopaedics
$854M

Similar metrics at other companies

STERIS logo
STESegment operating income — Segment operating income
$343.1M+7.2%
Baxter International logo
BAXReportable Segment — Segment operating income
$298M-25.5%
Walt Disney logo
DISEntertainment Segment — Segment operating income
$1.68B+64.4%
Walt Disney logo
DISExperiences Segment — Segment operating income
$3.02B+19.9%
Walt Disney logo
DISSports Segment — Segment operating income
$858M-17.3%
Comtech Telecommunications logo
CMTLAllerium — Segment operating income
$4.36M-47.8%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$129.28B-9.8%
Enterprise value$140.08B-11.2%
P/E34.7×-14.5×
P/S-1.0×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Segment ResultsThree Months / 2026Three Months / 2025
Corporate and Other$43$39
Amortization of intangible assets180167
Total depreciation and amortization$397$361
MedSurg and Neurotechnology$700$757
Orthopaedics846854
Segment operating income$1,546$1,611
Items not allocated to segments:
Corporate and Other$(275)$(267)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's medsurg and neurotechnology: — segment operating income?
Stryker (SYK) reported medsurg and neurotechnology: — segment operating income of $700M in Q1 2026.
How has Stryker's medsurg and neurotechnology: — segment operating income changed year-over-year?
Stryker's medsurg and neurotechnology: — segment operating income decreased by 7.5% year-over-year, from $757M to $700M.
What is the long-term trend for Stryker's medsurg and neurotechnology: — segment operating income?
Over 4 years (2021 to 2025), Stryker's medsurg and neurotechnology: — segment operating income has grown at a 12.3% compound annual growth rate (CAGR), from $2.81B to $4.46B.
What does medsurg and neurotechnology: — segment operating income mean?
Calculated as the segment's net sales minus its cost of sales, R&D, and SG&A expenses. This metric serves as the primary measure of the segment's profitability and operational performance before corporate-level allocations. It demonstrates the segment's ability to generate profit from its core business activities.

Ask your AI about Stryker's medsurg and neurotechnology: — segment operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude